Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Oogenesis

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...

Mutagenicity and Carcinogenicity

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

In Vitro Fertilization

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Characterization of external cross-talk from silicon photomultipliers in a liquid xenon detector.

The European physical journal. C, Particles and fields·2025

Same author

[DIFFICULTIES IN DISSECTION OF URINARY BLADDER IN TOTAL LAPAROSCOPIC HYSTERECTOMY.]

Akusherstvo i ginekologiia·2018

Same author

[Laparoscopic Operations in Ovarian Endometriosis.]

Akusherstvo i ginekologiia·2018

Same author

[PROGNOSTIC MODELS IN MODERN MANAGEMENT OF VULVAR CANCER].

Akusherstvo i ginekologiia·2016

Same author

[OPPORTUNITIES OF HIFU TECHNOLOGY FOR TREATMENT FIBROIDS DISEASES SUCH AS NON-INVASIVE AND ALTERNATIVE METHOD TO SURGERY].

Akusherstvo i ginekologiia·2016

Same author

[LOCALIZATION AND SIZE OF THE LESIONS IN PELVIC ENDOMETRIOSIS].

Akusherstvo i ginekologiia·2016

Search research articles

Related Experiment Video

Updated: Mar 16, 2026

Co-transplantation of Human Ovarian Tissue with Engineered Endothelial Cells: A Cell-based Strategy Combining Accelerated Perfusion with Direct Paracrine Delivery

Co-transplantation of Human Ovarian Tissue with Engineered Endothelial Cells: A Cell-based Strategy Combining Accelerated Perfusion with Direct Paracrine Delivery

Published on: May 16, 2018

[ASSISTED REPRODUCTIVE TECHNOLOGIES AND OVARIAN CANCEROGENESIS].

T Totev, T Tihomirova, S Tomov

Akusherstvo I Ginekologiia

|August 12, 2016

Summary

Assisted reproductive technologies (ART) drugs may play a role in ovarian cancer risk. More research is needed to understand the potential links between these fertility treatments and cancer development.

Area of Science:

Reproductive endocrinology and oncology.
Investigating the intersection of fertility treatments and cancer etiology.

Context:

Assisted reproductive technologies (ART) are widely used for infertility treatment.
The drugs administered during ART raise concerns regarding their potential impact on ovarian carcinogenesis.

Purpose:

To explore the potential role of ART drugs in the development of ovarian cancer.
To assess the risks associated with drug therapy in ART patients.

Summary:

The study examines the link between ART medications and ovarian cancer.
Current research findings are controversial and inconclusive.
Theoretical and epidemiological data suggest a need for caution in patients undergoing ART drug therapy.

Impact:

More Related Videos

Transplantation Into the Mouse Ovarian Fat Pad

Transplantation Into the Mouse Ovarian Fat Pad

Published on: September 7, 2016

Development of Mouse-Derived Organoid Lines from Fallopian Tube Epithelial Cells for High Grade Serous Ovarian Carcinoma Modeling

Development of Mouse-Derived Organoid Lines from Fallopian Tube Epithelial Cells for High Grade Serous Ovarian Carcinoma Modeling

Published on: August 6, 2025

Related Experiment Videos

Last Updated: Mar 16, 2026

Co-transplantation of Human Ovarian Tissue with Engineered Endothelial Cells: A Cell-based Strategy Combining Accelerated Perfusion with Direct Paracrine Delivery

Co-transplantation of Human Ovarian Tissue with Engineered Endothelial Cells: A Cell-based Strategy Combining Accelerated Perfusion with Direct Paracrine Delivery

Published on: May 16, 2018

Transplantation Into the Mouse Ovarian Fat Pad

Transplantation Into the Mouse Ovarian Fat Pad

Published on: September 7, 2016

Development of Mouse-Derived Organoid Lines from Fallopian Tube Epithelial Cells for High Grade Serous Ovarian Carcinoma Modeling

Development of Mouse-Derived Organoid Lines from Fallopian Tube Epithelial Cells for High Grade Serous Ovarian Carcinoma Modeling

Published on: August 6, 2025

Highlights the need for careful consideration of ART drug administration.
Emphasizes the importance of further research to clarify the risks.
Informs clinical practice and patient counseling regarding fertility treatments.